The Stomach in Diabetes: From Villain to Ally
, 11 November 2008
Michael Camilleri
Clinical Gastroenterology and Hepatology
March 2009 (Vol. 7, Issue 3, Pages 285-287) Abstract |
Full Text |
Full-Text PDF (321 KB)
In his discussions of treatment of diabetic gastroparesis, Dr Camilleri never clearly defines the use of metoclopramide. Other articles have emphasized that treatment beyond 3 months is associated with a 1%–10% incidence of tardive dyskinesia.
Alameda County Medical Center, Oakland, California
Conflicts of interest The authors disclose no conflicts.
PREVIEW